Mark Lee - HUTCHMED Insider
| H7T2 Stock | EUR 2.72 0.10 3.55% |
Insider
Mark Lee is Senior Vice President - Corporate Finance & Development of HUTCHMED LS 1 since 2019.
| Age | 41 |
| Tenure | 5 years |
| Phone | 852 2128 1188 |
| Web | http://www.hutch-med.com |
Mark Lee Latest Insider Activity
Tracking and analyzing the buying and selling activities of Mark Lee against HUTCHMED stock is an integral part of due diligence when investing in HUTCHMED. Mark Lee insider activity provides valuable insight into whether HUTCHMED is net buyers or sellers over its current business cycle. Note, HUTCHMED insiders must abide by specific rules, including filing SEC forms every time they buy or sell HUTCHMED'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Mark Lee over a year ago Payment of 52114 shares by Mark Lee of Forge Global subject to Rule 16b-3 |
HUTCHMED Management Efficiency
The company has return on total asset (ROA) of (0.1932) % which means that it has lost $0.1932 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2472) %, meaning that it generated substantial loss on money invested by shareholders. HUTCHMED's management efficiency ratios could be used to measure how well HUTCHMED manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Jin Nakayama | Casio Computer CoLtd | N/A | |
| Yuichi Masuda | Casio Computer CoLtd | N/A | |
| Richard Wohl | Computer And Technologies | 64 | |
| Kwok Ng | Computer And Technologies | 48 | |
| Tetsuo Kashio | Casio Computer CoLtd | N/A | |
| Allen Nicholson | Computer And Technologies | 56 | |
| Wai Cheung | Computer And Technologies | 58 | |
| King Leung | Computer And Technologies | 61 | |
| Nobuyuki Mochinaga | Casio Computer CoLtd | N/A | |
| Anthony Shing | Computer And Technologies | N/A | |
| Francene CPA | Computer And Technologies | 58 | |
| Takashi Kashio | Casio Computer CoLtd | N/A | |
| Tetsuro Izumi | Casio Computer CoLtd | N/A | |
| Bjarne Reinert | Lery Seafood Group | 41 | |
| David Farnsworth | Computer And Technologies | 66 | |
| Larry Zivelonghi | Computer And Technologies | N/A | |
| Yamynn DeAngelis | Computer And Technologies | 66 | |
| Engineer Ng | Computer And Technologies | 60 | |
| Michael Currie | Computer And Technologies | N/A | |
| Ivar Wulff | Lery Seafood Group | 49 | |
| Kazuhiro Kashio | Casio Computer CoLtd | 57 | |
Management Performance
| Return On Equity | -0.25 | |||
| Return On Asset | -0.19 |
HUTCHMED LS 1 Leadership Team
Elected by the shareholders, the HUTCHMED's board of directors comprises two types of representatives: HUTCHMED inside directors who are chosen from within the company, and outside directors, selected externally and held independent of HUTCHMED. The board's role is to monitor HUTCHMED's management team and ensure that shareholders' interests are well served. HUTCHMED's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, HUTCHMED's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Edith Shih, Company Secretary, Non-Executive Director | ||
| Chig Cheng, Chief Financial Officer, Executive Director | ||
| May Wang, Senior Vice President - business development & strategic alliances | ||
| Mark Lee, Senior Vice President - Corporate Finance & Development | ||
| Karen Ferrante, Independent Non-Executive Director | ||
| Christian Hogg, Chief Executive Officer, Executive Director | ||
| Weiguo Su, Chief Scientific Officer, Executive Director | ||
| Shu Mok, Independent Non-Executive Director | ||
| Graeme Jack, Independent Non-Executive Director | ||
| Zhenping Wu, Senior Vice President - Pharmaceutical Sciences | ||
| Dan Eldar, Non-Executive Director | ||
| Simon To, Executive Chairman of the Board | ||
| Paul Carter, Senior Independent Non-Executive Director |
HUTCHMED Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is HUTCHMED a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.25 | |||
| Return On Asset | -0.19 | |||
| Profit Margin | (0.64) % | |||
| Operating Margin | (0.95) % | |||
| Shares Outstanding | 864.77 M | |||
| Shares Owned By Insiders | 44.52 % | |||
| Shares Owned By Institutions | 54.43 % | |||
| Revenue | 400.81 M | |||
| Gross Profit | (201.19 M) | |||
| EBITDA | (373.29 M) |
Currently Active Assets on Macroaxis
Other Information on Investing in HUTCHMED Stock
HUTCHMED financial ratios help investors to determine whether HUTCHMED Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HUTCHMED with respect to the benefits of owning HUTCHMED security.